Morgan Joseph initiates coverage on Isis Pharmaceuticals (Nasdaq: ISIS) with a Buy.

Morgan Joseph analyst says, "In summary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE